Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

L.A. McKeown

June 18, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

Stay Vigilant for Mechanical Complications of Acute MI, Review Urges

Shelley Wood

December 11, 2020

News Daily News

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

Caitlin E. Cox

November 03, 2020

News Daily News

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

Shelley Wood

September 17, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

July 27, 2015

News Daily News

肺栓塞发作后，二级抗凝效果未持续

L.A. McKeown

July 13, 2015

News Industry News

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

July 13, 2015

News Daily News

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

L.A. McKeown

July 13, 2015

Advertisement

Frail Patients Stand to Gain Most From Cardiac Rehab

What’s Going to Be Hot at TCT 2025

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

May 2023 News Roundup

April 2023 News Roundup

New Faces, New Formats, New Tech: What to Expect From TCT 2022

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

April 2022 News Roundup

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

April 2021 News Roundup

Stay Vigilant for Mechanical Complications of Acute MI, Review Urges

Nationwide Data Shed Light on Timing, Predictors of Acute MI in Pregnancy

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Bellerophon Therapeutics Announces Top-Line Results From PRESERVATION I Clinical Trial for Bioabsorbable Cardiac Matrix - BCM

肺栓塞发作后，二级抗凝效果未持续

NICE recommends once-daily LIXIANA® (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults

Después de Sufrir un Embolismo Pulmonar el Beneficio de la Anticoagulación Secundaria No se Mantiene

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content